Dr Emma Hamilton is an Endocrinologist at Fiona Stanley and Fremantle Hospitals, Clinical Senior Lecturer at UWA and Clinical Lead of the Multidisciplinary Diabetes Foot Unit at Fiona Stanley Hospital, an NADC accredited Centre of Excellence High Risk Foot Service.  Emma completed her Endocrinology training in Western Australia before moving to Melbourne to complete a PhD “Control of Musculoskeletal Function and Body Composition by Androgens in Males” under the supervision of Professor Jeffrey Zajac and Dr Mathis Grossmann at the University of Melbourne, Austin Health. Since returning to WA, Emma continues to pursue her clinical and research interests in androgens, diabetes, osteoporosis and diabetes-related foot complications as well as a long term research collaboration with Professor Tim Davis and the Fremantle Diabetes Study team. Aligning her research priorities with her clinical work, Emma was awarded a Raine Clinician Research Fellowship to further her research in diabetes-related foot disease, with the aim of improving outcomes for people living with diabetes and foot complications. Emma serves on a number of national diabetes-related foot disease projects and committees including the NADC Diabetic Foot Network working party, NADC interdisciplinary High Risk Foot Service accreditation committee, the Foot Forward Executive Advisory team, the DFA Australian Research Priorities project, DFA Australian guidelines Wound Classification group and is also a member of the IWGDF Wound Classification guideline group.

Dr Michelle Kaminski is an Adjunct Lecturer in the Discipline of Podiatry at La Trobe University, with a particular interest in the prevention and management of foot ulceration in high-risk populations. In addition, Michelle is the Podiatry Research Lead at Monash Health and holds an Adjunct Senior Research Fellow position at Monash University. Michelle has experience in leading several large research projects within the public health and university sectors, and is passionate about embedding research into clinical practice and providing mentoring to junior researchers. Michelle is currently supervising 1 PhD student. Michelle's expertise is recognised by her current appointment as an editorial board member for the Journal of Wound Management; the official journal of the European Wound Management Association. Michelle is also a member of the Asia Pacific Diabetic Foot Ulcer Academics Club, where she is involved in conducting international research studies with leading experts in the field. A career highlight was an invitation by Diabetes Feet Australia to be a chapter group member for developing the new Australian diabetes-related foot disease guidelines, where she was secretary and first author of the Prevention Guideline. Michelle has published 17 peer-reviewed publications (10 as first/senior author, 1 book chapter, 1 national guideline). Her papers have been cited 322 times in the scientific literature, which equates to a Google Scholar h-index of 9 and an i10-index of 9. Michelle is currently involved in several research projects, including: investigations related to the prevention and management of foot ulceration in high-risk populations, the burden and impact of diabetes-related foot disease, musculoskeletal disorders of the foot and ankle, student motivators and barriers for studying podiatry, and the impact of foot problems related to cancer therapies. 

Dr Chen is a podiatrist and early career researcher specialising in diabetes-related foot disease. Having completed her PhD at UTAS, which focused on health literacy and improving diabetes-related foot ulcer prevention, she returned to WA for new challenges. Pam is currently developing a new multi-disciplinary foot ulcer service at Joondalup Health Campus and also works as a senior podiatrist at SCGH. Pam is the national President of the Advanced Practicing Podiatrists – High Risk Foot Group in Australia and sits on a number of committees and networks relating to diabetic foot disease nationally. She is passionate about translational research and evidence-based practice, and has more recently been involved with the 2021 Australian evidence-based guidelines for diabetes-related foot disease as Secretary of the Wound Healing chapter. Pam is also part of the International Working Group of the Diabetic Foot – 2023 update on Guidelines on the use of interventions to enhance healing of foot ulcers in persons with diabetes as scientific Secretary.

Associate Professor Pete Lazzarini is a podiatrist by background and is now a Principal Research Fellow with Queensland University of Technology and Queensland Health in Brisbane, Australia. Pete has an emerging international track record in diabetes-related foot disease research, and he holds an Early Career Fellowship with the Australian National Health and Medical Research Council. His research interests are in the epidemiology and treatment of foot disease and he is especially interested in research that prevents foot disease hospitalisation and amputation. He has published >125 papers, delivered >110 (inter)national conference presentations and attracted >$3.6 million in grant funding in the field. And he serves on multiple (inter)national diabetic foot committees, including immediate past Chair of Diabetes Feet Australia and Secretary of the International Working Group on the Diabetic Foot Offloading Guideline. Pete is particularly motivated by nurturing the next generation of researchers to develop policy and practice strategies that help end avoidable amputations within a generation.

Sean is a registered Podiatrist and Lecturer at Western Sydney University. Sean competed his undergraduate B.Podiatry  (2011), and  B. Health Science Hons (2012). Having completed his PhD in 2017 on 'Vascular risk profiling and exercise therapy for diabetic foot complications’, Sean has since co-authored 25 publications in the fields of diabetes, microvascular disease, obesity, neuropathy, First Nations health, exercise therapy, Charcot neuro-osteoarthropathy, peripheral artery disease, biomechanics, plantar pressure analysis, and mHealth.  Sean is also involved in cultural capability training associated with the Buridja outreach clinic, Wiradjuri Country, NSW, and is active in tertiary education and research supervision.

Dr Vivienne Chuter is a Professor at Western Sydney University. She leads a clinically based research program focusing on prevention and management of diabetes-related foot disease for Aboriginal and Torres Strait Islander people and for non-Indigenous Australians. Developed as a living lab model encompassing clinical, research and education elements, Vivienne’s research focuses on macro and microvascular complications of diabetes, including improving diagnosis of peripheral artery disease through more targeted clinical testing, as well as reducing risk of foot complications through conservative therapy and physical activity interventions. Committed to improving health and well-being for First Nations Australians, Vivienne provides academic leadership and clinical service provision to co-designed, community-led diabetes-related foot complications prevention and management services and research. This includes research relating to development and implementation of culturally safe care provision and strategies to develop cultural capability in new graduate practitioners.

Prof Rob Fitridge (MBBS, MS, FRACS) is Professor of Vascular Surgery at University of Adelaide, and Consultant Vascular Surgeon with the Central Adelaide Local Health Network (Royal Adelaide Hospital and The Queen Elizabeth Hospital). He is also head of the Multi-Disciplinary Foot (MDF) Service at The Queen Elizabeth Hospital and Lyell McEwin Health Service, which he co-founded in the mid-1990s, and is co-head of the MDF service at the Royal Adelaide Hospital. His contributions to surgical science have been recognised with an ad hominem membership with the Fellows of the Royal College of Surgeons in Edinburgh. He is most recognised for his work on predictive modelling of outcomes after endovascular aneurysm surgery (NHMRC-funded with 15 related publications). He was a member of the steering committee for the Global Guidelines for Chronic Limb-threatening Ischaemia (CLTI), and also contributed to the GLASS anatomical staging system and to the ESVS Acute Limb Ischaemia guideline. He is managing editor for Mechanisms of Vascular Disease: A Textbook for Vascular Specialists, widely used for training in Australia and now in its third edition. He is actively involved in undergraduate and postgraduate student teaching, as well as curriculum development for vascular surgical training. Prof Fitridge has extensive clinical and research experience in management of chronic complex wounds, with 20 publications in the last five years in the field of limb salvage with a combined citation index over seven times the field average. He was a member of the Baker IDI/NHMRC and Diabetes Feet Australia working groups, which developed national guidelines for the management of the diabetic foot; he is also a member of the International Working Group for the Diabetic Foot (and co-chair of its Peripheral Arterial Disease committee), which develops and updates internationally-recognised guidelines for the assessment and management of diabetes-related foot disease. Prof Fitridge is a core partner with the Australian Centre for Accelerating Diabetes Innovations (ACADI), where he is a lead in the diabetic foot syndrome priority area.